Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial

S. Stacchiotti, S. Ferrari, A. Redondo, N. Hindi-Muniz, E. Palmerini, M.A. Vaz Salgado, A.M. Frezza, P.G. Casali, A. Gutierrez, A. Lopez-Pousa, G. Grignani, A. Italiano, A. LeCesne, S. Dumont, J.Y. Blay, N. Penel, D. Bernabeu, E. de Alava, M. Karanian, C. MorosiS. Brich, G.P. Dagrada, V. Vallacchi, C. Castelli, M. Brenca, D. Racanelli, R. Maestro, P. Collini, J. Cruz, J. Martin-Broto

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)1252-1262
Number of pages11
JournalThe Lancet Oncology
Volume20
Issue number9
DOIs
Publication statusPublished - 2019

Cite this

Stacchiotti, S., Ferrari, S., Redondo, A., Hindi-Muniz, N., Palmerini, E., Vaz Salgado, M. A., Frezza, A. M., Casali, P. G., Gutierrez, A., Lopez-Pousa, A., Grignani, G., Italiano, A., LeCesne, A., Dumont, S., Blay, J. Y., Penel, N., Bernabeu, D., de Alava, E., Karanian, M., ... Martin-Broto, J. (2019). Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial. The Lancet Oncology, 20(9), 1252-1262. https://doi.org/10.1016/S1470-2045(19)30319-5